358 related articles for article (PubMed ID: 36556962)
21. Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease.
Zhou A; Lei Y; Tang L; Hu S; Yang M; Wu L; Yang S; Tang B
J Bacteriol; 2021 Jan; 203(4):. PubMed ID: 33077630
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory
Lai HC; Lin TL; Chen TW; Kuo YL; Chang CJ; Wu TR; Shu CC; Tsai YH; Swift S; Lu CC
Gut; 2022 Feb; 71(2):309-321. PubMed ID: 33687943
[TBL] [Abstract][Full Text] [Related]
23. [Lung and gut microbiota and their interaction with the carcinogenesis and development of lung cancer: a review].
Zhang Y; Zhang Y; Si H
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3789-3800. PubMed ID: 34841784
[TBL] [Abstract][Full Text] [Related]
24. Why is it worth remembering the lung microbiome in ICU patients?
Siwicka-Gieroba D; Barud M; Dabrowski W
Anaesthesiol Intensive Ther; 2021; 53(5):466-474. PubMed ID: 34816704
[TBL] [Abstract][Full Text] [Related]
25. Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Wang L; Hao K; Yang T; Wang C
Chin Med J (Engl); 2017 Sep; 130(17):2107-2111. PubMed ID: 28741603
[TBL] [Abstract][Full Text] [Related]
26. Microbiome Links Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease and Dietary Fiber via the Gut-Lung Axis: A Narrative Review.
Ding K; Chen J; Zhan W; Zhang S; Chen Y; Long S; Lei M
COPD; 2021 Dec; 19(1):10-17. PubMed ID: 34963421
[TBL] [Abstract][Full Text] [Related]
27. Bacterial microbiome of lungs in COPD.
Sze MA; Hogg JC; Sin DD
Int J Chron Obstruct Pulmon Dis; 2014; 9():229-38. PubMed ID: 24591822
[TBL] [Abstract][Full Text] [Related]
28. Emerging pathogenic links between microbiota and the gut-lung axis.
Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
[TBL] [Abstract][Full Text] [Related]
29. The Role of Oral Microbiota in Chronic Obstructive Pulmonary Disease.
Wen S; Zhang Z; Ouyang Y; Liu J; Liang Z; Pi Y; Su Z; Chen D; Guo L; Jiang Q; Yang L; Wang Y
Respiration; 2022; 101(9):859-868. PubMed ID: 35790142
[TBL] [Abstract][Full Text] [Related]
30. Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases.
Saint-Criq V; Lugo-Villarino G; Thomas M
Ageing Res Rev; 2021 Mar; 66():101235. PubMed ID: 33321253
[TBL] [Abstract][Full Text] [Related]
31. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
32. COPD and Gut-Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics.
Qu L; Cheng Q; Wang Y; Mu H; Zhang Y
Front Microbiol; 2022; 13():868086. PubMed ID: 35432269
[TBL] [Abstract][Full Text] [Related]
33. Microbiome effects on immunity, health and disease in the lung.
Shukla SD; Budden KF; Neal R; Hansbro PM
Clin Transl Immunology; 2017 Mar; 6(3):e133. PubMed ID: 28435675
[TBL] [Abstract][Full Text] [Related]
34. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
35. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease.
Bowerman KL; Rehman SF; Vaughan A; Lachner N; Budden KF; Kim RY; Wood DLA; Gellatly SL; Shukla SD; Wood LG; Yang IA; Wark PA; Hugenholtz P; Hansbro PM
Nat Commun; 2020 Nov; 11(1):5886. PubMed ID: 33208745
[TBL] [Abstract][Full Text] [Related]
36. The lung-gut crosstalk in respiratory and inflammatory bowel disease.
Du B; Fu Y; Han Y; Sun Q; Xu J; Yang Y; Rong R
Front Cell Infect Microbiol; 2023; 13():1218565. PubMed ID: 37680747
[TBL] [Abstract][Full Text] [Related]
37. Association of Intestinal Microbial Dysbiosis With Chronic Obstructive Pulmonary Disease.
Ananya FN; Ahammed MR; Fahem MM; Kafle S; Viswanathan M; Desai D; Akku R; Khan F; Hernandez TE; Bala SK; Gulati S; Martin N; Yatzkan GD; Pérez-Fernández J
Cureus; 2021 Nov; 13(11):e19343. PubMed ID: 34909304
[TBL] [Abstract][Full Text] [Related]
38. Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease.
Wang Y; Li N; Li Q; Liu Z; Li Y; Kong J; Dong R; Ge D; Li J; Peng G
Int J Chron Obstruct Pulmon Dis; 2021; 16():3317-3335. PubMed ID: 34916790
[TBL] [Abstract][Full Text] [Related]
39. Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation.
Cheng ZX; Zhang J
Chronic Obstr Pulm Dis; 2024 May; 11(3):311-325. PubMed ID: 38563747
[TBL] [Abstract][Full Text] [Related]
40. Effects of inhaled corticosteroids (ICS) on lung microbiota and local immune response in long-term treatment of chronic obstructive pulmonary disease (COPD): utility of titration and therapeutic index.
Toraldo DM; Rizzo E; Conte L
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):849-858. PubMed ID: 35435466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
